🧬 10 Key Updates from New American College of Cardiology Inpatient Heart Failure Recommendations

The medical field is undergoing a rapid transformation, with exciting breakthroughs in treatments, technology, and patient care. From revolutionary gene therapies to AI-driven diagnostics, the future of medicine is full of possibilities. We invite you to stay informed and explore these advancements with us. Join our community to stay ahead of the curve and discover how these changes could impact your health and well-being. Together, let's embrace the future of medicine! 🚀

By Michael Walter | August 08, 2024

Click here to learn more details about this article. 

Here are the key points from the article: 

The American College of Cardiology (ACC) has published new recommendations designed to help cardiologists and other healthcare providers provide optimal care to patients hospitalized with heart failure. The new expert consensus decision pathway (ECDP) replaces a similar document from 2019 and is to be used in conjunction with heart failure guidelines published in 2022 by the ACC, American Heart Association and Heart Failure Society of America.

10 important updates in the American College of Cardiology’s 2024 expert consensus decision pathway about patients hospitalized with heart failure

1. The writing committee emphasized the importance of sodium-glucose cotransporter (SGLT) inhibitor therapy during heart failure hospitalizations. Regardless of a patient’s left ventricular ejection fraction, the group wrote, SGLT inhibitors can be started at any time, and the other pillars can be brought in after the patient is stabilized.

2. Hospital admissions for a new diagnosis of heart failure when the patient is already in the emergency department should occur when there are “rapidly progressive symptoms, severe congestion or higher complexity of disease.” Some low-risk patients, meanwhile, may be able to receive care in an observation unit or even from the comfort of home.

3. The typical routes that end with heart failure hospital admission include “newly diagnosed heart failure, chronic heart failure with previous therapy or advanced heart failure with chronic Class IV symptoms despite previously recommended therapies.”

4. Daily trajectory reviews may reveal that the patient is progressing toward effective decongestion and stabilization for the initiation of neurohormonal therapies.

5. Daily trajectory reviews may indicate a patient is “stalling” after an initial response to therapy, failing to respond at all or exhibiting worsening symptoms. This could warrant “diuretic agent therapies, reconsideration of etiology, physiology and comorbidities, possible escalation to other therapies and re-evaluation of goals of care.”

6. SGLT inhibitors and mineralocorticoid antagonists can be initiated at any time and continued after discharge, unless a specific patient’s medical history suggests otherwise.

7. Any strategies focused on neurohormonal therapies of beta-adrenergic blocking agents and angiotensin receptor-neprilysin inhibitors (ARNIs)/ angiotensin-converting enzyme (ACE) inhibitor/angiotensin II receptor blockers (ARBs) should examine the patient’s history with each therapy as well as all relevant hemodynamic data and the patient’s kidney function.

8. The selection of an ARNI/ACE inhibitor/ARB or switching from an ACE inhibitor/ARB to ARNI are both indicated for treating HFrEF, and can “generally be initiated” in combination with beta-blockers after the patient has been stabilized. Steps should be taken to minimize the patient’s risk of hypotension or kidney dysfunction.

9. Detailed plans related to diagnoses, discharge and other helpful information should be provided to patients and their referring physicians. These documents can then be reviewed during follow-up phone calls and other appointments.

10. The writing committee highlighted the substantial role palliative care can play when helping patients “recognize progressive disease and re-evaluate goals of care.”

Ready to listen? Just tap to play! ⬇

Join our friendly community as we adapt to the new norm together and receive weekly insights for well-being. Check out the weekly newsletters. 

To stay up-to-date with our latest news and updates, you can subscribe to our newsletters here.